Immunocore
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $140M
Investors
- 10
About Immunocore
Immunocore, Ltd. specializes in the development of immunotherapeutic products. Founded in 2008 in Abingdon, UK, it has undergone strategic pivots to enhance its focus on T cell receptor technology.Immunocore Holdings plc develops innovative immunotherapeutic products that improve the immune system's ability to target and remove diseased cells. The core technology, ImmTAX, modifies T cell receptors to recognize and destroy tumor or infected cells while minimizing autoimmune responses.71 mn.Immunocore aims to expand its market presence by launching new bispecific T cell receptor therapies while targeting additional markets across North America, Europe, and Asia. The company plans to leverage its financial resources to enhance its operational capabilities and accelerate the delivery of its innovative therapies to the market.
Who invested in Immunocore
10 investors across 2 rounds
See all investors in Immunocore
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Immunocore
Who invested in Immunocore?
Immunocore has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immunocore raised?
Immunocore has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Immunocore last raise money?
Immunocore's most recent round on record is a Series C, in Dec 2020.
What does Immunocore do?
Immunocore is a biotechnology company.
Where is Immunocore headquartered?
Immunocore is headquartered in Abingdon, UK.
Which VCs invest in companies like Immunocore?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Immunocore's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Immunocore? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.